LENSAR, Inc. (LNSR) Stock Price & Analysis
LENSAR, Inc. (LNSR) closed at USD 6.03 on Thursday, October 15, 2026, down 1.31% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 6.11; the Oct 15, 2026 session ranged USD 6.03–6.24 on volume of 41,417 shares. Market capitalization is $74.08M, with a 52-week range of USD 4.95–12.94 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/LNSR.md
Key facts (LNSR)
- Analysts: Buy (mean 2.00 on a 1–5 scale) (3 analysts), mean target USD 11.33 (range 10–13).
- Total return with dividends: 1Y -49.0% vs S&P 500 +18.1%; 5Y -19.8% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD -0.14, revenue estimate $14.3M.
Analysts (LNSR)
Consensus Buy (mean 2.00 on a 1–5 scale), 3 analysts; mean target USD 11.33 (low 10, high 13).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-28 | LUCID CAPITAL MARKETS | Initiated | Buy | $11 |
| 2026-08-20 | BTIG | Target raised | Buy | $9 → $10 |
| 2026-08-13 | BTIG | Target raised | Buy | $7 → $9 |
Total return (dividends reinvested) (LNSR)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -49.0% | -19.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -49.1% | -4.3% |
| Volatility (annualized) | 69.7% | 66.1% |
| Max drawdown | -60.6% (Jan 2026→Jul 2026) | -72.6% (Mar 2022→Oct 2023) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 6.03 |
|---|---|
| Change | ▼ 1.31% (down) |
| Previous Close | USD 6.11 |
| Open | USD 6.11 |
| Day Range | USD 6.03 – 6.24 |
| 52-Week Range | USD 4.95 – 12.94 |
| Volume | 41,417 shares |
| Market Cap | $74.08M |
| Exchange | NCM |
Technical Analysis (LNSR)
Nexqual's technical model rates LNSR "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 22.43 (oversold) |
| vs SMA50 | Below (USD 7.41) |
| MACD | -0.35 (negative) |
Analyst Ratings (LNSR)
Wall Street analysts rate LNSR "Buy" based on 3 analysts, with a mean price target of USD 11.33 (range USD 10–13), per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 11.33 |
| High Target | USD 13 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (LNSR)
| Next Earnings Date | 2026-11-12 |
|---|---|
| EPS Estimate | USD -0.14 |
| Revenue Estimate | $14.30M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.1 vs est -0.27 ▲ beat |
| 2026-03-31 | USD -0.2 vs est 0.49 ▼ miss |
| 2025-12-31 | USD -0.11 vs est -0.1 ▼ miss |
| 2025-09-30 | USD -0.11 vs est -0.08 ▼ miss |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (LNSR)
| Total Revenue | $60.26M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +18.40% |
| Gross Margin | +48.34% |
| Operating Margin | +12.94% |
| Profit Margin | +57.57% |
| ROE | +357.30% |
| Debt / Equity | 0.08 |
| Current Ratio | 2.39 |
| Total Cash | $13.56M |
| Total Debt | $2.38M |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (LNSR)
Nexqual rates LENSAR, Inc.'s overall financial health "Solid" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Solid — Revenue +9% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 48%, operating 13% |
| Balance Sheet | Strong — $14M cash vs $2M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$7M (TTM) |
| Efficiency | Strong — ROE 357%, ROA -18.7% |
Ownership (LNSR)
| Insider Ownership | +21.52% |
|---|---|
| Institutional Ownership | +45.97% |
| Shares Outstanding | 12.29M |
| Float | 8.84M |
| Short % of Float | +3.63% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (LNSR)
LENSAR, Inc. is led by Nicholas T. Curtis (age 69), President, CEO & Director, per Nexqual as of October 16, 2026 at 05:21 UTC.
| President, CEO & Director | Nicholas T. Curtis (age 69) |
|---|---|
| Chief Operating Officer | Alan B. Connaughton (age 53) |
| Interim CFO & Principal Financial Officer and Secretary | Michael A. Rossi (age 51) |
Major Backers & Investors (LNSR)
Notable institutional backers of LENSAR, Inc. include Brandes Investment Partners L.P., Datum One Series Trust-BRANDES SMALL CAP VALUE FUND, Groupe La Francaise, according to Nexqual as of October 16, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Brandes Investment Partners L.P. | 8.75% |
| Datum One Series Trust-BRANDES SMALL CAP VALUE FUND | 4.34% |
| Groupe La Francaise | 1.74% |
| RBF Capital, LLC | 1.54% |
| CSS LLC | 1.33% |
| Credit Industriel Et Commercial | 1.18% |
| Kerrisdale Advisers, Llc | 1.13% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 6.76% |
| BlackRock | 1.77% |
| Dimensional Fund Advisors | 1.23% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ESTA | Establishment Labs Holdings Inc | USD 61.36 | ▲ 4.98% |
| ALMR | Alamar Biosciences, Inc. | USD 27.42 | ▲ 16.58% |
| INSP | Inspire Medical Systems, Inc. | USD 70.12 | ▲ 1.83% |
| BFLY | Butterfly Network, Inc. | USD 7.85 | ▼ 3.09% |
| AXGN | AxoGen, Inc. | USD 35.63 | ▼ 1.49% |
| UFPT | UFP Technologies, Inc. | USD 297.19 | ▲ 0.99% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt